July 13, 2018 – iSchemaView has signed Diagnostic Imaging Australia (DIA) to be the exclusive distributor for the RAPID ...
Intact Vascular Inc. announced the publication of the iDissection Classification trial results in the current issue of Journal of Invasive Cardiology.
Zebra Medical Vision has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Coronary Calcium Scoring algorithm. The algorithm, capable of automatically calculating a patient’s Agatston equivalent coronary calcium score from an electrocardiogram (ECG)-gated computed tomography (CT) scan, provides physicians with important data used in the assessment of the risk for coronary artery disease.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
CathWorks announced the approval of a new Current Procedural Terminology (CPT) code 0523T for non-invasive, 3-D FFRangio-enabled interpretation of possible atherosclerotic stenosis during coronary angiography interventions. The company said the code issuance is a major step forward in helping physicians objectively and cost-effectively determine if percutaneous coronary intervention (PCI) is indicated and revascularization has occurred in every coronary angiography procedure.
Placement of implantable cardioverter defibrillators (ICDs) not meeting Centers for Medicare and Medicaid Services (CMS) National Coverage Determination criteria declined following the announcement of a U.S. Department of Justice (DOJ) investigation into potential overuse of such devices. This conclusion was drawn from a recent study of hospitals participating in the NCDR ICD Registry.
French-based CorWave announced that its CALYPSO program has received 14 million euros to develop CorWave Neptune, a new type of cardiac support to improve the management of patients with severe heart failure. The CALYPSO Research and Development (R&D) program, with a total budget of 25 million euros over 4 years, will be partially financed with 14 million euros support from the Programme d'Investissements d'Avenir (Future Investments Program), managed by the Secrétariat Général pour l’Investissement (General Secretariat for Investment – SGPI) and operated by Bpifrance.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Following the Vest Prevention of Early Sudden Death Trial (VEST) presentation at the 2018 American College of Cardiology ...
July 10, 2018 — Evanston, Ill.-based startup Visura Technologies has received 510(k) clearance from the U.S. Food and ...
Ori Ben-Yehuda, M.D., executive director of the Cardiovascular Research Foundation Clinical Trial Center, discusses the ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
I attended the American Society of Echocardiography (ASE) 2018 meeting in June and have the following takeaways on ...
DAIC Editor Dave Fornell highlights some of the most innovative new technology on the show floor of the American Society ...
Partho Sengupta, M.D., DM, FACC, FASE, chief division of cardiology, director of cardiac imaging, West Virginia ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The Intersocietal Accreditation Commission (IAC) recently recognized the University of Tennessee Health Science Center (UTHSC) as the first mobile stroke unit in the world to achieve IAC Computed Tomography (CT) accreditation. A three-year accreditation in the areas of Neurological CT/Acute Stroke and Vascular CTA (Computed Tomography Angiography) was awarded to the UTHSC Mobile Stroke Unit in May 2018.
South Korea-based Healcerion launched the Sonon 300L wireless handheld ultrasound device to the U.S. market following U.S. Food and Drug Administration (FDA) approval. The Sonon 300L is designed to help primary care providers (PCPs) be more efficient and effective, with instant insight to diagnose or refer a patient to a specialist. The system provides flexible ultrasound technology at less than 1/10 the cost of a traditional ultrasound machine, with a user interface anyone can learn in minutes, according to the company.
A 3-D echo exam using the GE Vivid E95 ultrasound system at the American Society of Echocardiography (ASE) 2018. For ...